THE WELCH COMPANY
440 Davis Court #1602
San Francisco, CA 94111-2496
415 781 5700
rod@welchco.com
S U M M A R Y
DIARY: February 1, 2014 11:59 AM Saturday;
Rod Welch
VA full lab Labcor with lipid panel test cholesterol for LDL-P discordance.
1...Summary/Objective
2...Blood Tests Evaluate Health 4 Years After CABG x4 Surgery
........CBC........... 2014 02 01 1231 130529
3...Urinalysis Gross Exam Laboratory Test Satisfactory Within Range
........URINALYSIS.....2014 02 01 1231 120509
4...Total Bilirubin 1.6 Due to Rosuvastatin Recovery Failing
5...Salt Sodium Decreases Within Range Aligns Level Exercise
6...Glucose Decreases Within Range Still Higher than Expected
...........................ELECTROLYTES
7...LDL-C 81 LDL-P 861 LDL Size Large Hike 1000 Miles Weight Lose 15 Pounds
...........................LIPIDS
8...Rosuvastatin Switch from Simvastatin Myopathy Side Effects Decline
9...Simvistatin Side Effects Myopathy Muscle Pain Decline Switch to Rosuvastatin
10...Myopathy Muscle Pain Side Effects Simvistatin Decline Switch to Rosuvastatin
11...HGBA1c Diabetes Blood Test
12...Diabetes Blood Test HGBA1c
..............
Click here to comment!
CONTACTS
SUBJECTS
CBC Lab WBC 6.2 Labcorp Blood Test Results
1403 -
1403 - ..
1404 - Summary/Objective
1405 -
140501 - Follow up ref SDS 32 0000. ref SDS 30 0000.
140502 -
140503 - Blood test today shows excellent progress by the VA prescribing
140504 - continued weight loss, exercise, diet control and statin medications.
140505 - Lipid profile shows LDL-P well below 1000, ref SDS 0 IM9N, and LDL-P
140506 - size indicates large bouyant particles that protect against
140507 - arterialsclorosis and cardiovascular disease. ref SDS 0 IM9N Statin
140508 - drugs lowered LDL-C making patient concordant, higher risk for CVD
140509 - adverse events than for discordant condition. ref SDS 0 3V4N
140510 -
140511 -
140512 -
140514 - ..
1406 -
1407 -
1408 - Background
1409 -
140901 - On 131016 1632 submit letter for agenda meeting to review lab results
140902 - scheduled 131017 1000. ref SDS 33 X45G
140904 - ..
140905 - On 140131 0815 ordered another lab - cbc, electrolytes, lipid with NMR
140906 - - from Labcor to get LDL-P. ref SDS 42 X45G
140907 -
140908 -
140909 -
140911 - ..
1410 -
1411 -
1412 - Progress
1413 -
141301 - Blood draw today at non-VA health care facility for meeting at VA with
141302 - Doctor Alba on 140213, planned in the meeting on 131219 0930.
141303 - ref SDS 41 XF4O
141305 - ..
141306 - Blood draw today follows up previous partial lab on 131015 0724.
141307 - ref SDS 32 KK9M
141309 - ..
141310 - Planned for blood draw Monday or Tuesday next week, but injury
141311 - yesterday, perhaps from excessive hiking the past few months, reported
141312 - in case study on 120101 0900, ref SDS 14 WQ4I, prevents hiking today,
141313 - and possibly tomorrow as well. Since had a good hike yesterday, and
141314 - weight is near 165, decided to get blood draw today, so there is
141315 - correlation between labs, exercise, and weight.
141317 - ..
141318 - Last full lab was on 130529 0818. ref SDS 30 RP4N
141320 - ..
141321 - Prior full lab was on 121130 0846, ref SDS 24 RP4N, 120831 1400.
141322 - ref SDS 20 RP4N, following up 120509 1108, ref SDS 19 X45G; and before
141323 - that on 110727 1238, ref SDS 9 RP4N, and this was to prepare for
141324 - meeting in Primary Care a few weeks later on 110803 1400. ref SDS 10
141325 - U24I
141327 - ..
141328 - Partial lab to resolve skewed results from dehydration was on 121212
141329 - 0941. ref SDS 26 KK9M
141331 - ..
141332 - Prior partial for lipid panel testing cholesterol and for glucose,
141333 - sodium, and total bilirubin was on 131015 0724, ref SDS 32 KK9M,
141334 - following up partial lab on 120831 1400. ref SDS 20 IM9N and
141335 - ref SDS 20 KK9M
141337 - ..
141338 - Yesterday, placed lab order # 27716 with Health Testing Centers,
141339 - reported on 140131 0815, ref SDS 42 ZM5F, and confirmed with the
141340 - letter later that day, also shown on 140131 0815. ref SDS 42 XW7M
141342 - ..
141343 - Another letter from Health Testing Centers lists locations where blood
141344 - draws can be performed by Labcor. The only location where the work
141345 - can done on the weekend is...
141346 -
141347 - LABCORP
141348 - 1450 TREAT BLVD. WALNUT CREEK, CA 94595
141349 - Phone:925-937-1954 Hours:MONDAY-FRIDAY 6:30AM-9:00PM
141350 - SATURDAY 8:00AM-5:00PM
141351 - SUNDAY 9:00AM-5:00PM
141353 - ..
141354 - Called and talked to Janel.
141356 - ..
141357 - Janel found on Labcorp computer lab order # 27716 associated with
141358 - Labcorp documentation identified with...
141359 -
141360 - LabCorp
141361 - COR ORDER
141362 -
141363 - Account....................... 09419602
141364 - Req/Control................... 9619620
141366 - ..
141367 - Physican Information
141368 -
141369 - Name.................. Dlugos, Scott
141370 - NPI................... 1790748234
141371 - UPIN.................. F81666
141373 - ..
141374 - Patient Identification
141381 - ..
141382 - Order Code
141383 -
141384 - 001545 Alanine Aminotransferase (ALT/SGPT)
141385 - 319417 CMP12 + 8AC + CBC/D/Plt + UA
141386 - 884247 NMR LipoProfile
141387 -
141389 - ..
141390 - Total cost................ $188 .... 140131 0815, ref SDS 42 DY40
141392 - ..
141393 - Post expense ledger...
141396 -
141398 - ..
141399 - Drove to Labcorp and met with Janel.
141401 - ..
141402 - Blood draw for following labs...
141403 -
141404 - [On 140203 1147 obtained blood draw at VA to cross check
141405 - Labcorp blood test. 140203 1147, ref SDS 43 KK9M
141406 -
141408 - ..
141409 - Blood Tests Evaluate Health 4 Years After CABG x4 Surgery
141410 -
141411 - Follow up ref SDS 32 RP4N, ref SDS 30 RP4N.
141412 -
141413 - Labcorp
141414 - Telephone............................... 954 485 3322
141416 - ..
141417 - For inquiries, the physician may contact....
141418 -
141419 - Branch....................... 800-762-4344
141420 - Lab.......................... 858-668-3700
141422 - ..
141423 - Rte..................................... 28
141425 - ..
141426 - Patient Report
141427 - Specimen ID............................. 032-544-3972-0
141428 - Control ID.............................. 9619620
141429 - Account................................. 09419602
141436 - ..
141437 - Health Testing Centers
141438 - 2760 W Oakland Park Boulevard
141439 - Fort Lauderdale, FL 33311
141441 - ..
141442 - Patient Details
141443 -
141444 - 1. DOB............................... 1945 03 01
141445 - 2. Age (y/m/d)....................... 068/11/00
141446 - 3. Gender............................ M
141447 - 4. SSN...............................
141450 - ..
141451 - Specimen Details
141452 -
141453 - 1. Date collected.................... 2014 02 01 1231 Local
141454 - 2. Date entered...................... 2014 02 01
141455 - 3. Date reported..................... 2014 02 05 1808 ET
141457 - ..
141458 - Physician Details
141459 -
141460 - 1. Ordering.......................... S DLUGOS
141461 - 2. Referring.........................
141462 - 3. ID................................ F81666
141463 - 4. NPI............................... 1790748234
141465 - ..
141466 - Ordered Items
141467 - CMP12+8AC+CBC/D/Plt+UA; NMR LipoProfile; ALT (SGPT); Venipuncture;
141468 - Cardiovascular Risk Assessment
141470 - ..
141471 - Prior VA CBC on 120509 1108. ref SDS 19 RP4N
141472 - Prior VA CBC on 120831 1524. ref SDS 20 RP4N
141473 - Prior VA CBC on 121130 1001. ref SDS 24 RP4N
141474 - Prior VA CBC on 130529 0818. ref SDS 30 RP4N
141476 - ..
141477 - Labcorp performed blood test today...
141479 - ..
141480 - CBC........... 2014 02 01 1231 130529
141481 - Labcorp VA VA Labcorp
141482 - Blood Results Results Units Range Range
141483 - WBC 6.2 7.4 K/cmm 4.8 - 10.8 3.4 - 10.8
141484 - RBC 5.13 5.09 M/cmm 4.7 - 6.1 4.14 - 5.80
141485 - HGB 15.2 15.0 g/dL 14 - 18 12.6 - 17.7
141486 - HCT 44.2 46.2 % 42 - 52 37.5 - 51.0
141487 - MCV 86.0 90.7 fL 80 - 99 79.0 - 97.0
141488 - MCH 29.6 29.5 uug 27 - 34 26.6 - 33.0
141489 - MCHC 34.4 32.5 gm/dL 32 - 35.2 31.5 - 35.7
141490 - RDW 13.7 14.4 % 11.5 - 14.5 12.3 - 15.4
141491 - PLT 303 279 K/cmm 130 - 400 155.0 - 379.0
141492 - MPV 8.8 fL 7 - 10.4
141493 - NEUT % 69 69.9 % 40 - 80 40.0 - 74.0
141494 - LYMPH % 21 L 19.7 % 20 - 51 14.0 - 46.0
141495 - MONO % 8 7.8 % 2 - 13 4.0 - 12.0
141496 - EOS % 1 1.9 % .5 - 7 0.0 - 5.0
141497 - BASO % 1 0.7 % 0 - 2 0.0 - 3.0
141498 - NEUT # 4.3 5.2 K/cmm 1.5 - 7.9 1.4 - 7.0
141499 - LYMPH # 1.3 1.5 K/cmm 1.2 - 3.4 0.7 - 3.1
141500 - MONO # 0.5 0.6 K/cmm .2 - 1.2 0.1 - 0.9
141501 - EOS # 0.1 0.1 K/cmm .1 - .5 0.0 - 0.4
141502 - BASO # 0.1 0.1 K/cmm 0 - .2 0.0 - 0.2
141503 - ESRmVES mm/hr 0 - 10
141504 - ESRxCYT mm/hr 2 - 10
141505 - RETIC % % .66 - 2.85
141506 - RETIC # k/uL 27.9 - 121.6
141507 - Immature Granulocytes 0.0 % 0.0 - 2.0
141508 - Immature Grans (Abs) 0.0 % 0.0 - 0.1
141510 - ..
141511 - Comments:
141512 -
141513 - a. Test Performed at...
141514 - Health Testing Centers
141515 - 2760 W. OAKLAND PARK BLVD.
141516 - FORT LAUDERDALE FL 33311
141517 -
141518 -
141519 -
141520 -
1416 -
SUBJECTS
Urinalysis Gross Exam Laboratory Test Satisfactory Within Range Labc
2303 -
230401 - ..
230402 - Urinalysis Gross Exam Laboratory Test Satisfactory Within Range
230403 -
230404 - Follow up ref SDS 19 0X72, ref SDS 8 0X72.
230405 -
230406 - Prior Urinalysis test on 101207 0906. ref SDS 8 0X72
230407 - Prior Urinalysis test on 120509 1108. ref SDS 19 0X72
230409 - ..
230410 - URINALYSIS.....2014 02 01 1231 120509
230411 - Labcorp VA VA Labcorp
230412 - Results Results Units Range Range
230413 - PH 5.5 6.0 5 - 9 5.0 - 7.5
230414 - PROTEIN NEG NEG mg/dL NEG - TRACE NEG - TRACE
230415 - GLUCOSE NEG NEG mg/dL Ref: NEG NEG
230416 - KETONES NEG NEG mg/dL Ref: NEG NEG
230417 - BILI NEG NEG Ref: NEG NEG
230418 - BILIcnf Ref: NEG
230419 - BLOOD TRACE TRACE Ref: NEG
230420 - NITRITE, URINE NEG NEG Ref: NEG NEG
230421 - UROBILI 0.2 0.2 EU/dL .2 - 1 0.0 - 1.9
230422 - LEU EST NEG Ref: NEG
230423 - SP.GRAV 1.026 1.025 1.003- 1.035 1.005 - 1.030
230424 - COLOR YELLOW YELLOW
230425 - APPEAR CLEAR CLEAR
230426 - WBC ESTERASE NEG
230427 - OCCULT BLOOD NEG NEG
230429 - ..
230430 - Comments:
230431 -
230432 - a. Test Performed at...
230433 - Health Testing Centers
230434 - 2760 W. OAKLAND PARK BLVD.
230435 - FORT LAUDERDALE FL 33311
230436 -
230437 -
230438 -
230439 -
2305 -
SUBJECTS
Lab Electrolytes Chem Profile Glucose 98 Sodium NA 140 Potasium K 4.
3203 -
320401 - ..
320402 - Total Bilirubin 1.6 Due to Rosuvastatin Recovery Failing
320403 - Salt Sodium Decreases Within Range Aligns Level Exercise
320404 - Glucose Decreases Within Range Still Higher than Expected
320405 -
320406 - Follow up ref SDS 32 KK9M, ref SDS 30 KK9M.
320407 -
320408 - Prior CHEM PROFILE on 120509 1108. ref SDS 19 KK9M
320409 - Prior CHEM PROFILE on 120831 1524. ref SDS 20 KK9M
320410 - Prior CHEM PROFILE on 130228 1140. ref SDS 28 KK9M
320411 - Prior CHEM PROFILE on 130529 0818. ref SDS 30 KK9M
320412 - Prior CHEM PROFILE on 131015 0724. ref SDS 32 KK9M
320414 - ..
320415 - On 140131 0815 ordered another lab - cbc, electrolytes, lipid - from
320416 - Labcorpto get NMR test for LDL-P added to lipid panel. ref SDS 42 X45G
320418 - ..
320419 - ELECTROLYTES
320421 - ..
320422 - CHEM PROFILE...2014 02 01 1231 131015 130529
320423 - Labcorp VA VA VA Labcorp
320424 - PLASMA Results Results Results Units Range Range
320425 - GLUCOSE 98 108 H 120 mg/dL 74 - 118 65.0 - 99.0
320426 - GLUfast mg/dL Ref: <=99
320427 - NA (salt) 140 139 139 mmol/L 136 - 144 134.0 - 144.0
320428 - K (potasium) 4.8 4.3 H 4.9 mmol/L 3.4 - 4.8 3.5 - 5.2
320429 - CL 102 105 105 mmol/L 98 - 106 97.0 - 108.0
320430 - CO2 37.0 30.0 mmol/L 23 - 33
320431 - BUN 20 24 18 mg/dL 8 - 26 10.0 - 22.0
320432 - CREAT 0.81 0.83 0.83 mg/dL .5 - 1.1 0.76 - 1.27
320433 - eGFR INA 91 >60 >60 mL/min Ref: >=60 >59
320434 - eGFR IA 106 mL/min >59
320435 - CALCIUM 9.4 9.2 9.2 mg/dL 8.7 - 10.2 8.6 - 10.2
320436 - CA CORR mg/dL 8.7 - 10.2
320437 - PO4 mg/dL 2.4 - 4.5
320438 - MG mg/dL 1.8 - 2.5
320439 - ALK PHO 105 84 87 IntUnits/L 37 - 107 39.0 - 117.0
320440 - ..
320441 - T. BIL H 1.6 H 1.7 H 1.3 mg/dL .3 - 1.2 0.0 - 1.2
320442 - D. BILI 0.34 < 0.1 mg/dL .1 - .4 0.00 - 0.40
320443 - Bilirubin, Indir H 1.26 H mg/dL 0.10 - 0.80
320444 - AST 21 20 22 IntUnits/L 8 - 42 0.0 - 40.0
320445 - ALT 19 17 19 IntUnits/L 5 - 55 0.0 - 44.0
320446 - ALBUMIN 4.4 3.9 4.0 g/dL 3.3 - 4.8 3.6 - 4.8
320447 - PROTEIN 6.5 7.1 7.2 g/dL 6.5 - 8.1 6.0 - 8.5
320448 - Globulin, Total 2.1 g/dL 1.4 - 4.5
320449 - A/G Ratio 2.1 1.1 - 2.5
320450 - LDH 180.0 IntUnits/L 90 - 208 0.0 - 225.0
320451 - GGT 9.0 IU/L 0.0 - 65.0
320452 - Iron, Serum 114.0 ug/dL 40.0 - 155.0
320453 - AMYLASE Units/L 28 - 100
320454 - LIPASE Units/L 7 - 58
320455 - NH3 mcmol/L 15 - 56
320456 - URIC AC mg/dL 4.8 - 8.7
320457 - Cholesterol, Total 162.0 mg/dL 100.0 - 199.0
320458 - Triglycerides 64.0 mg/dL 0.0 - 149.0
320460 - ..
320461 - Comments:
320462 -
320463 - a. Test Performed at...
320464 - Health Testing Centers
320465 - 2760 W. OAKLAND PARK BLVD.
320466 - FORT LAUDERDALE FL 33311
320468 - ..
320469 - Bilirubin remains 50% high after ending Rosuvastatin 14 months ago on
320470 - 121206 0900, ref SDS 25 OS5L, indicating chornic side effects.
320471 - Peripheral neuropathy has declined from most severe effects; there
320472 - have been no symptoms for past 9 months, since 130614, reported in
320473 - case study on 120101 0900. ref SDS 14 TSUY Prior to 130614, there
320474 - were no episodes for several months reported on 130402, ref SDS 14
320475 - RURT, until episode occurred on 130210. ref SDS 14 PV8I Major
320476 - peripheral neuopathy both feet on 130107. ref SDS 14 8H5F
320478 - ..
320479 - Background on Rosuvastatin causing elevated T Bilirubin with
320480 - associated severe side effects is reported on 121206 0900, ref SDS 25
320481 - NI9L, and further explained in the record on 121130 0846. ref SDS 24
320482 - ER4K
320484 - ..
320485 - On 131017 1000 doctor explained patient history of intermittant and
320486 - mild peripheral neuropathy that correlates with persistent elevated T
320487 - Bilirubin in lab on 131015, ref SDS 32 015M, and further reported with
320488 - vitals, diet and exercise since prior meeting at VA on 130603, see
320489 - case study on 120101 0900, ref SDS 14 X14N, suggests intervention is
320490 - not required at this time to improve recovery from side effects taking
320491 - Rosuvastatin. ref SDS 35 LV5J
320493 - ..
320494 - On 131017 1000 VA medical chart Progress Notes assessment report
320495 - doctor concerned about chronic hyperbilirubinemia. ref SDS 35 PSXT
320496 -
320497 -
320498 -
320499 -
320500 -
320501 -
320502 -
320503 -
3206 -
SUBJECTS
Labcorp Lab Lipid Cholesterol 156 Decrease with Medication Hiking 10
4203 -
420401 - ..
420402 - LDL-C 81 LDL-P 861 LDL Size Large Hike 1000 Miles Weight Lose 15 Pounds
420403 -
420404 - Follow up ref SDS 32 IM9N, ref SDS 30 IM9N.
420405 -
420406 - Results today reported by Labcor using NMR technology align with
420407 - increased hiking and weight loss past 3 months, reported in case study
420408 - on 120101 0900, ref SDS 14 LO5O, and reflect changes in diet and
420409 - medication, reported on 140202, in the same study. ref SDS 14 GH4M
420411 - ..
420412 - Prior LIPID PANEL 120509 1108. ref SDS 19 IM9N
420413 - Prior LIPID PANEL 120831 1525. ref SDS 20 IM9N
420414 - Prior LIPID PANEL 130228 1140. ref SDS 28 IM9N
420415 - Prior LIPID PANEL 130529 0818. ref SDS 30 IM9N
420416 - Prior LIPID PANEL 131015 0724, ref SDS 32 IM9N
420418 - ..
420419 - LIPIDS
420420 -
420421 - 2014 02 01 1231 131015 130529
420422 - Labcorp VA VA VA Labcorp
420423 - NMR LipoProfile Results Results Results Units Range Range
420424 - LDL
420425 - LDL-P 861.0 nmol/L < 1000
420426 - <ow < 1000
420427 - Moderate 1000 - 1299
420428 - Borderline High 1300 - 1599
420429 - High 1600 - 2000
420430 - Very High > 2000
420432 - ..
420433 - Lipids
420434 - CHOL 156 321 H 307 mg/dL Ref: <=200 < 200
420435 - TRIGLYC 68 109 85 mg/dL Ref: <=150 < 150
420436 - HDL-C 61 50 50 mg/dL Ref: >=40 >= 40
420437 - LDL-C 81 249 H 240 mg/dL Ref: <=160 < 100
420438 - LDL Dir mg/dL Ref: <=160
420439 - TRIG NF mg/dL Ref: <=150
420440 - non-HDL-C 95 0 - 129
420442 - ..
420443 - LDL and HDL Particles
420444 - HDL-P (Total) 31.4 umol/L >= 30.5
420445 - Small LDL-P < 90.0 umol/L <=527.0
420446 - LDL Size 21.3 nm > 20.5
420448 - ..
420449 - --------------------------------------------------------
420450 - ** INTERPRETATIVE INFORMATION**
420451 - PARTICLE CONCENTRATION AND SIZE
420453 - ..
420454 - LDL AND HDL PARTICLES Percentile in Reference Population
420455 - HDL-P (total) High 75th 50th 25th Low
420456 - >34.9 34.9 30.5 26.7 <25.7
420457 - ..
420458 - Small LDL-P Low 25th 50th 75th High
420459 - <117 117 527 839 >839
420461 - ..
420462 - LDL Size <- Large (Pattern A)-> <- (Pattern B) ->
420463 - 23.0 20.6 20.5 19.0
420465 - ..
420466 - --------------------------------------------------------
420467 - Insulin Resistance Score
420468 - LP-IR Score < 25.0 <= 45.0
420469 -
420470 - The LP-IR Score combines information from lipoprotein
420471 - particle concentration and size to give improved
420472 - assessment of insulin resistance and diabetes risk.
420473 - Small LDL-P, LDL Particle Size, HDL-Particle, and
420474 - LP-IR Score have been validated by LipoScience
420475 - but not cleared by US FDA; the clinical utility
420476 - of these test results has not been fully established.
420478 - ..
420479 - INSULIN RESISTANCE MARKER
420480 -
420481 - <--Insulin Sensitive Insulin Resistant-->
420482 - Percentile in Reference Population
420483 -
420484 - Insulin Resistance Score
420485 - LP-IR Score Low 25th 50th 75th High
420486 - <27 27 45 63 >63
420487 -
420489 - ..
420490 - Comments:
420491 -
420492 - a. Test Performed at...
420493 - Health Testing Centers
420494 - 2760 W. OAKLAND PARK BLVD.
420495 - FORT LAUDERDALE FL 33311
420497 - ..
420498 - b. Medical Director's Note: On November 12, 2013, the ACC/AHA
420499 - released new guidelines on cholesterol treatment in adults
420500 - (Stone NJ et al. 2013 ACC/AHA guideline on the treatment of
420501 - blood cholesterol to reduce atherosclerotic cardiovascular
420502 - risk in adults: a report of the American College of
420503 - Cardiology/American Heart Association Task Force on
420504 - Practice Guidelines. Circulation. 2013; 00:000-000.) The
420505 - new guidelines do not make a recommendation for or against
420506 - use of LDL-C or non-HDL-C targets, but instead identify
420507 - patient groups who would benefit from statin therapy.
420508 - Until a consensus has been reached, the suggestions in this
420509 - report continue to reflect the ATP III guidelines. For
420510 - Interpretations, please refer to Litholink CDS Patient
420511 - Report.
420513 - ..
420514 - c. VA Evaluation for LDL-CHO:
420515 -
420516 - RISK CATEGORY LDL GOAL
420517 - CHD and CHD risk equivalents <100 mg/dL
420518 - Multiple (2+) risk factors <130 mg/dL
420519 - 0-1 risk factor <160 mg/dL
420521 - ..
420522 - HDL Chol. greater than/equal to 60 mg/dL counts as
420523 - "negative" risk factor; its presence removes 1 risk factor
420524 - from the total count.
420526 - ..
420527 - Ref: Adult Treatment Panel III (ATP III) JAMA 5/16/01 Vol.
420528 - 285 #19.
420529 -
420530 -
420532 - ..
420533 - Follow up prior lipid history on 121130 0846. ref SDS 24 W25L.
420534 - ..
420535 - Small LDL LP-IR
420536 - Collection DT CHOL TRIGL HDL LDL-C LDL-P HDL-P LDL-P SIZE SCORE
420537 - 02/01/2014 12:31 156 H 68 61 81 861 31.4 < 90 21.3 < 25 ..... ref SDS 0 BE6O
420538 - 10/15/2013 08:25 321 H 109 50 249 H ......................................... ref SDS 32 BE6O
420539 - 05/29/2013 08:18 307 H 85 50 240 H ......................................... ref SDS 28 BE6O
420540 - 02/28/2013 08:39 310 H 73 47 248 H ......................................... ref SDS 28 BE6O
420541 - 11/30/2012 10:01 173 53 57 105 ......................................... ref SDS 24 BE6O
420542 - 08/31/2012 15:25 176 94 47 110 ......................................... ref SDS 20 U89N
420543 - 05/09/2012 11:24 155 76 49 94 ......................................... ref SDS 19 U89N
420544 - 02/09/2012 11:18 285 82 41 228 H ......................................... ref SDS 15 2A4G
420545 - 11/17/2011 14:27 260 84 43 200 H ......................................... ref SDS 13 2A4G
420546 - 07/27/2011 12:58 163 81 45 102 ......................................... ref SDS 9 E19L
420547 - 12/07/2010 09:17 151 41 47 96 ......................................... ref SDS 8 E19L
420548 - 07/21/2010 08:54 261 H 87 35 L 209 H ......................................... ref SDS 4 E19L
420549 - 06/10/2010 10:33 217 H 83 36 L 164 H ......................................... ref SDS 3 QV4F
420550 - * 12/14/2009 11:10 241 H 136 44 170 H ......................................... 100928 0706, ref SDS 5 VW6J
420551 - 08/13/2009 15:09 233 H 118 30 L 179 H ......................................... 100610 1046, ref SDS 3 U45G
420552 - 06/16/2006 10:59 238 H 68 32 L 192 H ......................................... 091002 0900, ref SDS 1 LJ5H
420553 -
420554 - * Lab at VA San Francisco Medical Center reported on 100928 0706.
420555 - ref SDS 5 VW6J
420557 - ..
420558 - Graph of LDL history shown on 120209 1118. ref SDS 15 7M42
420560 - ..
420561 - Research on cholesterol reported on 091002 0900. ref SDS 1 2F8K
420563 - ..
420564 - On 131125 0005 research found ezetimibe (zetia) mg added to
420565 - Atorvastatin 20 mg yielded significantly greater changes to HDL and
420566 - Triglycerides (TG), than taking Atorvastatin in higher doses, e.g., 20
420567 - or 40 mg. ref SDS 38 CO56
420569 - ..
420570 - On 131125 0005 research found discordance LDL-P low and LDL-C high
420571 - lipid panel HDL 65 TG 77 healthy patient profile with LDL 246.
420572 - ref SDS 40 MN98 Discordance with LDL-P low and LDL-C high is lowest
420573 - risk for CVD, arterialsclorosis. 131125 0005, ref SDS 38 FM6L
420575 - ..
420576 - On 131125 0005 research further found CT tests can evaluate level of
420577 - plaque build up resulting from elevated cholesterol. ref SDS 39 N73K
420578 -
420579 -
420580 -
420581 -
420582 -
4206 -
SUBJECTS
Default Null Subject Account for Blank Record
4603 -
460401 - ..
460402 - Rosuvastatin Switch from Simvastatin Myopathy Side Effects Decline
460403 - Simvistatin Side Effects Myopathy Muscle Pain Decline Switch to Rosuvastatin
460404 - Myopathy Muscle Pain Side Effects Simvistatin Decline Switch to Rosuvastatin
460405 -
460406 - Follow up ref SDS 32 D26G, ref SDS 19 D26G.
460407 -
460408 - Prior Cardiac Enzymes Profile on 120209 1118. ref SDS 15 D26G
460409 - Prior Cardiac Enzymes Profile on 120509 1108. ref SDS 19 D26G
460410 - Prior Cardiac Enzymes, 131015 0724, ref SDS 32 D26G
460412 - ..
460413 - This test not performed by Labcorp with blood draw on 140201...
460414 -
460415 - CARDIAC ENZYMES.2013 10 15 0825 120509
460416 - PLASMA Results Results Units Range
460417 - CK 110 152 IntUnits/L 36 - 340
460418 - TRPONIN ng/ml 0 - 0.07
460419 - CK-MB ng/ml 0.6 - 3.5
460420 - MYOGLOB ng/ml 20 - 82
460422 - ..
460423 - a. TEST PERFORMED BY VAMC SACRAMENTO, 10535 HOSPITAL WAY,
460424 - MATHER CA.
460426 - ..
460427 - Research on 111013 explains Creatine Kinase CK, relates to muscle
460428 - disorders caused by cholesterol medications with statins. 111013 1404,
460429 - ref SDS 12 J54K
460431 - ..
460432 - Decrease in CK lab may align with reduced side effects of muscle pain
460433 - in left shoulder.
460434 -
460435 -
460436 -
460437 -
460438 -
460439 -
4605 -
SUBJECTS
Default Null Subject Account for Blank Record
6603 -
660401 - ..
660402 - HGBA1c Diabetes Blood Test
660403 - Diabetes Blood Test HGBA1c
660404 -
660405 - Follow up ref SDS 32 9F4O, ref SDS 8 IL4N.
660406 -
660407 - Prior HGBA1c Profile on 100721 0800. ref SDS 4 IL4N
660408 - Prior HGBA1c Profile on 101207 0906. ref SDS 8 IL4N
660409 - Prior HGBA1c Profile on 131015 0724. ref SDS 32 9F4O
660411 - ..
660412 - This test not performed by Labcorp with blood draw on 140201...
660413 -
660414 - HGBA1c......... 2013 10 15 0825 101207
660415 - BLOOD Results Results Units Range
660416 - HGBA1c 5.5 5.7 % 4.1 - 6
660417 - eAG 111 mg/dL 74 : - 118
660419 - ..
660420 - Comments:
660421 -
660422 - b. TEST PERFORMED BY VA MARTINEZ, 150 MUIR ROAD, MARTINEZ CA.
660423 -
660424 - eAG = Calculated Estimated Average Daily Glucose and may be
660425 - easier for patients to understand than an A1c result.
660426 - Calculation: 28.7 x HGBA1c - 46.7
660428 - ..
660429 - Ordering Provider: Harkesh S. Sandhu MD
660430 - Report Released: Oct 15, 2013 @ 1309
660432 - ..
660433 - Reporting Lab: MARTINEZ OPC/CREC
660434 - 150 MUIR ROAD MARTINEZ, CA 94553-4668
660436 - ..
660437 - Performing Lab: MARTINEZ OPC/CREC
660438 - 150 MUIR ROAD MARTINEZ, CA 94553-4668
660439 -
660441 - ..
660442 - This test for diabetes was ordered by Doctor Abrams during a meeting
660443 - at the San Francisco VA Medical Center on 130227 0930. ref SDS 27 8T5L
660444 - However, it is not reported for the lab performed the next day on
660445 - 130228 1140, ref SDS 28 RP4N, nor in the follow up lab 3 months later
660446 - on 130529 0818. ref SDS 30 RP4N
660448 - ..
660449 - HGGA1c was performed previously on 101207 0906, ref SDS 8 IL4N, and 5
660450 - months earlier on 100721 0800. ref SDS 4 IL4N
660452 - ..
660453 - Report today shows no evidence of diabetes.
660454 -
660455 -
660456 -
660457 -
660458 -
660459 -
660460 -
660461 -